Market Place
Sourcing Support
SHINE Donates Cancer Therapy Doses Through Oncidium Collaboration
17 Oct 2024 //
PR NEWSWIRE
SHINE Technologies Partners With UW-Madison On Cancer Treatments
17 Oct 2024 //
PR NEWSWIRE
GlyTherix & SHINE Partner to Advance Radiotherapy for Aggressive Cancers
18 Sep 2024 //
PR NEWSWIRE
SHINE Showcases FLARE, World`s Most Powerful Fusion Neutron System
22 Jul 2024 //
PR NEWSWIRE
SHINE, BlueEarth Partner For First Ilumira Supply From New Facility
06 Jun 2024 //
PR NEWSWIRE
SHINE Executives to Speak at Fusion Industry Association Annual Conference
19 Mar 2024 //
PR NEWSWIRE
SHINE Technologies to Exhibit at 7th Annual Theranostics World Congress
18 Mar 2024 //
PR NEWSWIRE
Radiopharm & SHINE Tech Announce Agreement for Cancer-Fighting Medical Isotope
19 Sep 2022 //
PRNEWSWIRE
SHINE Technologies Submits DMF to FDA for Non-Carrier-Added Lu-177 Chloride
29 Jul 2022 //
PRNEWSWIRE
SHINE and Telix Pharmaceuticals Enter Clinical Supply Agreement
11 Feb 2022 //
CONTRACTPHARMA
Telix and SHINE partner for Lutetium-177 Supply
10 Feb 2022 //
GLOBENEWSWIRE
SHINE Appoints Experienced ESG, Global Marketing Executives to BOD
18 Mar 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.